p jak2 Search Results


93
Bioss jak2(y1007+y1008) (6e5) monoclonal antibody
Jak2(Y1007+Y1008) (6e5) Monoclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2(y1007+y1008) (6e5) monoclonal antibody/product/Bioss
Average 93 stars, based on 1 article reviews
jak2(y1007+y1008) (6e5) monoclonal antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Novus Biologicals nbp2 67429
Nbp2 67429, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nbp2 67429/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
nbp2 67429 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
Novus Biologicals p jak2
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
P Jak2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p jak2/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
p jak2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GeneTex p-janus kinase 2 (jak2) antibody
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
P Janus Kinase 2 (Jak2) Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-janus kinase 2 (jak2) antibody/product/GeneTex
Average 90 stars, based on 1 article reviews
p-janus kinase 2 (jak2) antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
RayBiotech inc p-jak2 (py1007/1008, pel-jak2-y1007-1)
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
P Jak2 (Py1007/1008, Pel Jak2 Y1007 1), supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-jak2 (py1007/1008, pel-jak2-y1007-1)/product/RayBiotech inc
Average 90 stars, based on 1 article reviews
p-jak2 (py1007/1008, pel-jak2-y1007-1) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
ImmunoWay Biotechnology Company anti-phospho-jak1-y1022/1023 yp0154
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
Anti Phospho Jak1 Y1022/1023 Yp0154, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-phospho-jak1-y1022/1023 yp0154/product/ImmunoWay Biotechnology Company
Average 90 stars, based on 1 article reviews
anti-phospho-jak1-y1022/1023 yp0154 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Abbomax Inc p-jak2 (y1007 + 1008) antibody
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
P Jak2 (Y1007 + 1008) Antibody, supplied by Abbomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-jak2 (y1007 + 1008) antibody/product/Abbomax Inc
Average 90 stars, based on 1 article reviews
p-jak2 (y1007 + 1008) antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Abbexa Ltd rabbit anti- mice pjak2
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
Rabbit Anti Mice Pjak2, supplied by Abbexa Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti- mice pjak2/product/Abbexa Ltd
Average 90 stars, based on 1 article reviews
rabbit anti- mice pjak2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

94
Bioss jak2(tyr1007+tyr1008) antibody
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
Jak2(Tyr1007+Tyr1008) Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2(tyr1007+tyr1008) antibody/product/Bioss
Average 94 stars, based on 1 article reviews
jak2(tyr1007+tyr1008) antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
Kemin Industries rabbit anti-p-jak2
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
Rabbit Anti P Jak2, supplied by Kemin Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-p-jak2/product/Kemin Industries
Average 90 stars, based on 1 article reviews
rabbit anti-p-jak2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
EnoGene Inc p-jak2 no. e38pa1629
Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of <t>HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3.</t> G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).
P Jak2 No. E38pa1629, supplied by EnoGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-jak2 no. e38pa1629/product/EnoGene Inc
Average 90 stars, based on 1 article reviews
p-jak2 no. e38pa1629 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

N/A
The Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) from Novus is a Jak2 antibody to Jak2. This antibody reacts with Human. The Jak2 antibody has been validated for the following applications: Western Blot, ELISA, Immunohistochemistry,
  Buy from Supplier

Image Search Results


Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3. G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Article Title: Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m 6 A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.

doi: 10.1016/j.phymed.2021.153823

Figure Lengend Snippet: Fig. 4. The HKDC1 (m6A 2854 site) and HKDC1 protein levels in the HepG2 cells after treatment with siRNA fragments derived from m6A-related genes. A, The normalized level of HKDC1 (m6A 2854 site) treated with METTL3 siRNA. B, The normalized level of HKDC1 (m6A 2854 site) treated with METTL14 siRNA. C, The normalized level of HKDC1 (m6A 2854 site) treated with FTO siRNA. D, The normalized level of HKDC1 (m6A 2854 site) treated with ALKBH5 siRNA. E, The normalized level of HKDC1 (m6A 2854 site) treated with YTHDF1 siRNA. F, The protein bands of HKDC1/(p-)JAK2/(p-)STAT1/(cleaved-)caspase-3. G, The p-JAK/ JAK, p-STAT1/STAT1, and (cleaved-)caspase-3/caspase-3 ratios. The data are presented as mean ± SD, * p < 0.05 compared with the normal group, and & p < 0.05 compared with the high glucose + gene siRNA group (n = 3).

Article Snippet: The primary antibodies used in this study included p-JAK2, JAK2, p-STAT1, STAT1, cleaved-caspase-3, caspase-3, and β-actin (Santa Cruz Biotechnology, California, USA), anti-human HKDC1 antibody was purchased from Novus Biologicals Inc. (Colorado, USA).

Techniques: Derivative Assay

Fig. 6. The protein levels of the p-JAK2/ STAT1/cleaved-caspase-3 pathway in the HepG2 cells at different glucose concentra tions. A, The western blot bands of the HKDC1 and p-JAK2/STAT1/cleaved-caspase-3 pathway. B, Statistical data of the protein expression levels. C, The p-JAK2/JAK2, p- STAT1/STAT1, and cleaved-caspase-3/caspase- 3 ratios. All data are presented as mean ± SD, * p < 0.05 compared with the normal group, and # p < 0.05 compared with the high glucose group (n = 3).

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Article Title: Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m 6 A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.

doi: 10.1016/j.phymed.2021.153823

Figure Lengend Snippet: Fig. 6. The protein levels of the p-JAK2/ STAT1/cleaved-caspase-3 pathway in the HepG2 cells at different glucose concentra tions. A, The western blot bands of the HKDC1 and p-JAK2/STAT1/cleaved-caspase-3 pathway. B, Statistical data of the protein expression levels. C, The p-JAK2/JAK2, p- STAT1/STAT1, and cleaved-caspase-3/caspase- 3 ratios. All data are presented as mean ± SD, * p < 0.05 compared with the normal group, and # p < 0.05 compared with the high glucose group (n = 3).

Article Snippet: The primary antibodies used in this study included p-JAK2, JAK2, p-STAT1, STAT1, cleaved-caspase-3, caspase-3, and β-actin (Santa Cruz Biotechnology, California, USA), anti-human HKDC1 antibody was purchased from Novus Biologicals Inc. (Colorado, USA).

Techniques: Western Blot, Expressing